Literature DB >> 29053043

Entropion and ectropion repair: a snapshot of surgical practice in the United Kingdom.

Katherine Anne Mcveigh1, Rhys Harrison1, Rebecca Ford1.   

Abstract

We aim to provide a snapshot of the current surgical practice for correction of entropion and ectropion, the two most common oculoplastic procedures carried out in the UK, by surveying 135 consultant oculoplastic surgeons via the tool Survey Monkey. Forty-seven (35%) consultants responded. For entropion, 44% of surgeons opted for lateral tarsal strip (LTS) + everting sutures (ES). Other first-line choices included LTS + transcutaneous retractor plication (21%), Quickert's procedure (14%), ES (7%), and Wies procedure (5%). Important patient-related factors to consider were horizontal lid laxity and retractor dehiscence. Regarding ectropion, LTS was most commonly practiced (35%), followed by LTS + transconjunctival retractor plication (28%), wedge excision (16%), and lateral canthoplasty (5%). The patient-related factors guiding choice were horizontal lid laxity, lateral canthal tendon laxity, and punctal position under traction. Responses found a wide range of preferred surgical techniques in practice. The factors guiding surgical choice were personal audit results (92% stated important/very important), familiarity with the technique (92%), and the technique being favoured by previous trainers (76%), suggesting current practice led by expert opinion, possibly due to a lack of evidence-based literature. This highlights the variety of core oculoplastic surgical techniques practiced and underlines the need for robust trials to guide surgical choice.

Entities:  

Keywords:  Entropion; current practice; ectropion; surgery

Mesh:

Year:  2017        PMID: 29053043     DOI: 10.1080/01676830.2017.1383461

Source DB:  PubMed          Journal:  Orbit        ISSN: 0167-6830


  1 in total

1.  Complications Associated with Polydek Sutures Used in Eyelid Lateral Tarsal Strip Procedures.

Authors:  Lin Chen; Robert B Penne
Journal:  Clin Med Res       Date:  2022-01-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.